|
시장보고서
상품코드
2152171
프라임 편집 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 용도별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)Prime Editing Market Size, Share & Trends Analysis Report By Component, By Application, By End User, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
프라임 편집 시장 요약
세계 프라임 편집 시장 규모는 2025년에 8억 6,170만 달러로 평가되며, 2026년 10억 6,800만 달러에서 2033년까지 50억 7,680만 달러로 성장할 것으로 예상되며, 2026년부터 2033년까지의 연평균 성장률(CAGR)은 24.9%에 달할 것으로 전망됩니다.
북미가 시장을 주도하고 있으며, 2025년에는 세계 시장의 46.0%라는 최대 점유율을 차지했습니다. 시장 성장은 정밀한 유전체 변형을 위한 프라임 편집의 채택 확대, 유전자 편집 및 유전성 질환 연구 분야의 활발한 연구개발 활동, 그리고 CRISPR 기반 기술, 전달 시스템 및 치료 용도의 발전에 의해 주도되고 있습니다.
시장 역학
프라임 편집 시장은 정밀 유전체 편집, 유전자 치료, 기능 유전체학에 대한 투자 확대와 더불어 프라임 에디터 기술 및 전달 시스템의 발전에 힘입어 강력한 성장을 이루고 있습니다. 차세대 편집 플랫폼의 개발이 진행되고, 프라임 편집이 치료 용도로 응용되는 사례가 증가하고 있는 점이 시장 확대를 뒷받침할 것으로 예상됩니다. 또한, 생체 내 전달, PEG-RNA의 최적화, 고처리량 편집 플랫폼의 발전은 물론, 유전성 질환 연구, 맞춤형 의료, 농업 생명공학 분야에서의 응용 확대가 맞물려 시장 성장을 위한 새로운 기회가 창출되고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법 및 범위
제2장 요약
제3장 시장 : 변수, 동향, 범위
- 시장 계보 전망
- 시장 역학
- 업계 분석 도구
제4장 구성요소별 비즈니스 분석
- 프라임 편집 시장 : 구성요소별 동향 분석
- 시약 및 키트
- 상품/플랫폼
- 서비스
제5장 용도별 비즈니스 분석
- 프라임 편집 시장 : 용도별 동향 분석
- 기초·학술 조사
- 치료제 개발
- 세포주 및 바이오 제조
- 농업·작물 생명공학
제6장 최종사용자별 비즈니스 분석
- 프라임 편집 시장 : 최종사용자별 동향 분석
- 학술 연구 기관
- 생명공학·제약 기업
- CRO/CDMO
- 기타
제7장 지역별 비즈니스 분석
- 프라임 편집 시장 점유율 : 지역별, 2025년 및 2033년
- 북미
- 북미 프라임 편집 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽 프라임 편집 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양 프리미엄 편집 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카 프라임 편집 시장, 2021-2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- MEA 프라임 편집 시장, 2021-2033년
- 남아프리카
- 사우디아라비아
- UAE
- 쿠웨이트
제8장 경쟁 현황
- 기업 분류
- 기업 점유율 및 포지셔닝 분석, 2025년
- 전략 매핑
- 기업 개요 목록
- Prime Medicine, Inc.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Integrated DNA Technologies, Inc.
- GenScript
- Synthego
- Agilent Technologies, Inc.
- ToolGen, Inc.
- Takara Bio Inc.
- New England Biolabs
Prime Editing Market Summary
The global prime editing market size was valued at USD 861.7 million in 2025 and is projected to grow from USD 1,068.0 million in 2026 to USD 5,076.8 million by 2033, at a CAGR of 24.9% from 2026 to 2033. North America dominated the market, accounting for the largest share of 46.0% of the global market in 2025. Market growth is driven by the increasing adoption of prime editing for precise genome modification, rising research and development activities in gene editing and genetic disease research, and advancements in CRISPR-based technologies, delivery systems, and therapeutic applications.
Market Dynamics
The prime editing market is experiencing strong growth, driven by rising investments in precision genome editing, genetic medicine, and functional genomics, as well as advancements in prime editor technologies and delivery systems. The growing development of next-generation editing platforms and the increasing translation of prime editing into therapeutic applications are expected to support market expansion. Moreover, advancements in in vivo delivery, pegRNA optimization, and high-throughput editing platforms, coupled with rising applications in genetic disease research, personalized medicine, and agricultural biotechnology, are creating new opportunities for market growth.
Global Prime Editing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global prime editing market report on the basis of component, application, end user, and region:
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Reagents & Kits
- Instruments/Platforms
- Services
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Basic/Academic Research
- Therapeutics Development
- Cell Line & Biomanufacturing
- Agricultural & Crop Biotechnology
- End User Outlook (Revenue, USD Million, 2021 - 2033)
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- CROs/CDMOs
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Component Segment
- 1.1.1.2. Application Segment
- 1.1.1.3. End User Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising Demand for Precise Genome Editing Technologies
- 3.2.1.2. Growing R&D Activities in Gene Editing and Genetic Medicine
- 3.2.1.3. Expansion of Personalized and Precision Medicine
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Complexity of Prime Editing Workflows
- 3.2.2.2. Limited In Vivo Editing Efficiency
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. Component Business Analysis
- 4.1. Segment Dashboard
- 4.2. Prime Editing Market: Component Movement Analysis
- 4.3. Reagents & Kits
- 4.3.1. Reagents & Kits Market, 2021 - 2033 (USD Million)
- 4.4. Instruments/Platforms
- 4.4.1. Instruments/Platforms Market, 2021 - 2033 (USD Million)
- 4.5. Services
- 4.5.1. Services Market, 2021 - 2033 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Segment Dashboard
- 5.2. Prime Editing Market: Application Movement Analysis
- 5.3. Basic/Academic Research
- 5.3.1. Basic/Academic Research Market, 2021 - 2033 (USD Million)
- 5.4. Therapeutics Development
- 5.4.1. Therapeutics Development Market, 2021 - 2033 (USD Million)
- 5.5. Cell Line & Biomanufacturing
- 5.5.1. Cell Line & Biomanufacturing Market, 2021 - 2033 (USD Million)
- 5.6. Agricultural & Crop Biotechnology
- 5.6.1. Agricultural & Crop Biotechnology Market, 2021 - 2033 (USD Million)
Chapter 6. End User Business Analysis
- 6.1. Segment Dashboard
- 6.2. Prime Editing Market: End User Movement Analysis
- 6.3. Academic & Research Institutes
- 6.3.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
- 6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
- 6.5. CROs/CDMOs
- 6.5.1. CROs/CDMOs Market, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Prime Editing Market Share By Region, 2025 & 2033
- 7.2. North America
- 7.2.1. North America Prime Editing Market, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. U.S. Prime Editing Market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Canada Prime Editing Market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Mexico Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. UK Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Germany Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. France Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Italy Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Spain Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Denmark Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Sweden Prime Editing Market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Norway Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Japan Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. China Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. India Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Australia Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Thailand Prime Editing Market, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. South Korea Prime Editing Market, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Prime Editing Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Brazil Prime Editing Market, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Argentina Prime Editing Market, 2021 - 2033 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Prime Editing Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. South Africa Prime Editing Market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Saudi Arabia Prime Editing Market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. UAE Prime Editing Market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Kuwait Prime Editing Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Company Market Share/ Position Analysis, 2025
- 8.3. Strategy Mapping
- 8.4. Company Profiles/Listing
- 8.4.1. Prime Medicine, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Integrated DNA Technologies, Inc.
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. GenScript
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Synthego
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Agilent Technologies, Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. ToolGen, Inc.
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Takara Bio Inc.
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. New England Biolabs
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Prime Medicine, Inc.
